558 related articles for article (PubMed ID: 26503987)
21. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
[TBL] [Abstract][Full Text] [Related]
22. Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension.
Lambert M; Boet A; Rucker-Martin C; Mendes-Ferreira P; Capuano V; Hatem S; Adão R; Brás-Silva C; Hautefort A; Michel JB; Dorfmuller P; Fadel E; Kotsimbos T; Price L; Jourdon P; Montani D; Humbert M; Perros F; Antigny F
Cardiovasc Res; 2018 May; 114(6):880-893. PubMed ID: 29360952
[TBL] [Abstract][Full Text] [Related]
23. Alterations in pharmacological action of the right ventricle of monocrotaline-induced pulmonary hypertensive rats.
Daicho T; Yagi T; Takano S; Marunouchi T; Abe Y; Ohara M; Takeo S; Tanonaka K
Biol Pharm Bull; 2009 Aug; 32(8):1378-84. PubMed ID: 19652377
[TBL] [Abstract][Full Text] [Related]
24. A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension.
Lee JH; Park BK; Oh KS; Yi KY; Lim CJ; Seo HW; Lee BH
Int Immunopharmacol; 2016 Nov; 40():196-202. PubMed ID: 27611861
[TBL] [Abstract][Full Text] [Related]
25. Beta1-adrenoceptor antagonist, metoprolol attenuates cardiac myocyte Ca
Fowler ED; Drinkhill MJ; Norman R; Pervolaraki E; Stones R; Steer E; Benoist D; Steele DS; Calaghan SC; White E
J Mol Cell Cardiol; 2018 Jul; 120():74-83. PubMed ID: 29807024
[TBL] [Abstract][Full Text] [Related]
26. Endogenous production of ghrelin and beneficial effects of its exogenous administration in monocrotaline-induced pulmonary hypertension.
Henriques-Coelho T; Correia-Pinto J; Roncon-Albuquerque R; Baptista MJ; Lourenço AP; Oliveira SM; Brandão-Nogueira A; Teles A; Fortunato JM; Leite-Moreira AF
Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2885-90. PubMed ID: 15331358
[TBL] [Abstract][Full Text] [Related]
27. BK
Ferraz AP; Seara FAC; Baptista EF; Barenco TS; Sottani TBB; Souza NSC; Domingos AE; Barbosa RAQ; Takiya CM; Couto MT; Resende GO; Campos de Carvalho AC; Ponte CG; Nascimento JHM
Cardiovasc Drugs Ther; 2021 Aug; 35(4):719-732. PubMed ID: 33245463
[TBL] [Abstract][Full Text] [Related]
28. Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats.
Leong ZP; Okida A; Higuchi M; Yamano Y; Hikasa Y
Vascul Pharmacol; 2018 Jan; 100():41-50. PubMed ID: 29100963
[TBL] [Abstract][Full Text] [Related]
29. Progesterone inhibits vascular remodeling and attenuates monocrotaline-induced pulmonary hypertension in estrogen-deficient rats.
Tofovic PS; Zhang X; Petrusevska G
Prilozi; 2009 Jul; 30(1):25-44. PubMed ID: 19736529
[TBL] [Abstract][Full Text] [Related]
30. Hydroxysafflor yellow A (HSYA) attenuates hypoxic pulmonary arterial remodelling and reverses right ventricular hypertrophy in rats.
Li L; Dong P; Hou C; Cao F; Sun S; He F; Song Y; Li S; Bai Y; Zhu D
J Ethnopharmacol; 2016 Jun; 186():224-233. PubMed ID: 27063983
[TBL] [Abstract][Full Text] [Related]
31. Distinct right ventricle remodeling in response to pressure overload in the rat.
Mendes-Ferreira P; Santos-Ribeiro D; Adão R; Maia-Rocha C; Mendes-Ferreira M; Sousa-Mendes C; Leite-Moreira AF; Brás-Silva C
Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H85-95. PubMed ID: 27199115
[TBL] [Abstract][Full Text] [Related]
32. Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
da Silva Gonçalves Bós D; Van Der Bruggen CEE; Kurakula K; Sun XQ; Casali KR; Casali AG; Rol N; Szulcek R; Dos Remedios C; Guignabert C; Tu L; Dorfmüller P; Humbert M; Wijnker PJM; Kuster DWD; van der Velden J; Goumans MJ; Bogaard HJ; Vonk-Noordegraaf A; de Man FS; Handoko ML
Circulation; 2018 Feb; 137(9):910-924. PubMed ID: 29167228
[TBL] [Abstract][Full Text] [Related]
33. Impact of dietary iron restriction on the development of monocrotaline-induced pulmonary vascular remodeling and right ventricular failure in rats.
Naito Y; Hosokawa M; Hao H; Sawada H; Hirotani S; Iwasaku T; Okuhara Y; Eguchi A; Hirota S; Ohyanagi M; Tsujino T; Masuyama T
Biochem Biophys Res Commun; 2013 Jun; 436(2):145-51. PubMed ID: 23707944
[TBL] [Abstract][Full Text] [Related]
34. Pathophysiology of infantile pulmonary arterial hypertension induced by monocrotaline.
Dias-Neto M; Luísa-Neves A; Pinho S; Gonçalves N; Mendes M; Eloy C; Lopes JM; Gonçalves D; Ferreira-Pinto M; Leite-Moreira AF; Henriques-Coelho T
Pediatr Cardiol; 2015 Jun; 36(5):1000-13. PubMed ID: 25608696
[TBL] [Abstract][Full Text] [Related]
35. Bortezomib alleviates experimental pulmonary arterial hypertension.
Kim SY; Lee JH; Huh JW; Kim HJ; Park MK; Ro JY; Oh YM; Lee SD; Lee YS
Am J Respir Cell Mol Biol; 2012 Nov; 47(5):698-708. PubMed ID: 22842494
[TBL] [Abstract][Full Text] [Related]
36. Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil.
Mouchaers KT; Schalij I; de Boer MA; Postmus PE; van Hinsbergh VW; van Nieuw Amerongen GP; Vonk Noordegraaf A; van der Laarse WJ
Eur Respir J; 2010 Oct; 36(4):800-7. PubMed ID: 20351034
[TBL] [Abstract][Full Text] [Related]
37. Biventricular structural and functional responses to aortic constriction in a rabbit model of chronic right ventricular pressure overload.
Apitz C; Honjo O; Humpl T; Li J; Assad RS; Cho MY; Hong J; Friedberg MK; Redington AN
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1494-501. PubMed ID: 22818124
[TBL] [Abstract][Full Text] [Related]
38. Effects of a pure alpha/beta-adrenergic receptor blocker on monocrotaline-induced pulmonary arterial hypertension with right ventricular hypertrophy in rats.
Ishikawa M; Sato N; Asai K; Takano T; Mizuno K
Circ J; 2009 Dec; 73(12):2337-41. PubMed ID: 19822980
[TBL] [Abstract][Full Text] [Related]
39. Iptakalim ameliorates monocrotaline-induced pulmonary arterial hypertension in rats.
Li J; Long C; Cui W; Wang H
J Cardiovasc Pharmacol Ther; 2013 Jan; 18(1):60-9. PubMed ID: 22947433
[TBL] [Abstract][Full Text] [Related]
40. Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension.
Falcão-Pires I; Gonçalves N; Henriques-Coelho T; Moreira-Gonçalves D; Roncon-Albuquerque R; Leite-Moreira AF
Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H2007-14. PubMed ID: 19346461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
